4.5 Editorial Material

Mipomersen, an antisense apolipoprotein B synthesis inhibitor

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Peripheral Vascular Disease

Development of Apolipoprotein B Antisense Molecules as a Therapy for Hyperlipidemia

Tiffany Thomas et al.

CURRENT ATHEROSCLEROSIS REPORTS (2010)

Review Biochemistry & Molecular Biology

Apolipoprotein B synthesis inhibition: results from clinical trials

Maartje E. Visser et al.

CURRENT OPINION IN LIPIDOLOGY (2010)

Editorial Material Pharmacology & Pharmacy

Mipomersen as a potential adjunctive therapy for hypercholesterolemia

Neeraj Patel et al.

EXPERT OPINION ON PHARMACOTHERAPY (2010)

Article Biochemistry & Molecular Biology

Effect of apolipoprotein-B synthesis inhibition on liver triglyceride content in patients with familial hypercholesterolemia

Maartje E. Visser et al.

JOURNAL OF LIPID RESEARCH (2010)

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

Fatima Akdim et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

News Item Biotechnology & Applied Microbiology

Safety signal dampens reception for mipomersen antisense

Jim Kling

NATURE BIOTECHNOLOGY (2010)

Article Peripheral Vascular Disease

Novel Nonstatin Strategies to Lower Low-Density Lipoprotein Cholesterol

Michael H. Davidson

CURRENT ATHEROSCLEROSIS REPORTS (2009)

Article Medicine, General & Internal

Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness

Allen J. Taylor et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Simvastatin with or without ezetimibe in familial hypercholesterolemia

John J. P. Kastelein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Cardiac & Cardiovascular Systems

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

Frederick F. Samaha et al.

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)

Review Pharmacology & Pharmacy

MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?

John R. Burnett et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2007)

Review Biotechnology & Applied Microbiology

Antisense oligonucleotides as therapeutics for hyperlipidaemias

RM Crooke

EXPERT OPINION ON BIOLOGICAL THERAPY (2005)

Review Biochemistry & Molecular Biology

Familial hypobetalipoproteinemia: genetics and metabolism

G Schonfeld et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2005)

Article Chemistry, Medicinal

Tissue disposition of 2 '-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys

RZ Yu et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2004)